5 Small-Cap Stocks to Buy According to Australian Billionaire Kerr Neilson
In this article, we discuss the top 5 small-cap stocks to buy according to Australian Billionaire Kerr Neilson.
Esperion Therapeutics Inc. (ESPR)
Get Email AlertsSector: Pharmaceutical Preparations
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Platinum Asset Management Kerr Neilson | 1,713,176 | $36,234 | +8% | 0.83% |
| 2. | Marshall Wace LLP Paul Marshall And Ian Wace | 1,172,070 | $24,789 | +14% | 0.11% |
| 3. | Rhenman & Partners Asset Management Henrik Rhenman | 572,267 | $12,103 | -4% | 0.82% |
| 4. | 382,300 | $8,086 | +334% | 0% | |
| 5. | Millennium Management Israel Englander | 316,933 | $6,703 | -2% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $20.22 | 100,000 | Large Shareholder | 4,477,964 | 2021-05-24 | Filing | |
| $20.37 | 200,000 | Large Shareholder | 4,377,964 | 2021-05-19 | Filing | |
| $20.57 | 80,000 | Large Shareholder | 4,177,964 | 2021-05-06 | Filing | |
| $20.02 | 150,000 | Large Shareholder | 4,097,964 | 2021-05-05 | Filing | |
| $25.31 | 200,000 | Large Shareholder | 3,947,964 | 2020-11-03 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $43.62 | 1,500 | Officer | 11,092 | 2019-04-03 | Filing | |
| $42.71 | 6,500 | Officer | 12,592 | 2019-04-03 | Filing | |
| $45.25 | 1,700 | Director | 0 | 2019-03-19 | Filing | |
| $44.66 | 13,629 | Director | 1,700 | 2019-03-19 | Filing | |
| $50.06 | 25,000 | Director | 548,726 | 2019-03-12 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 2,818,835 | $33,967 | 11.66% | |
| 2. | 260,959 | $3,145 | 0.05% | |
| 3. | 48,800 | $588 | 0% | |
| 4. | 12,200 | $125 | 0.02% | |
| 5. | 400 | $5 | 0% |
News See All
10 Best Healthcare Stocks to Buy According to Matthew Halbower’s Pentwater Capital Management
In this article, we discuss the 10 best healthcare stocks to buy according to Matthew Halbower's Pentwater Capital Management.
10 Best High Short Interest Stocks to Buy Now
In this article, we discuss the 10 best high short interest stocks to buy now.
Esperion Therapeutics, Inc. (ESPR): Are Hedge Funds Right About This Stock?
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilities...
Is It Too Late to Buy Esperion Therapeutics (ESPR) Stock?
Wasatch Micro Cap Value Fund recently released its Q4 2020 Investor Letter, a copy of which you can download here.
Is Esperion Therapeutics (ESPR) a Smart Long-term Buy?
Wasatch Micro Cap Fund recently released its Q4 2020 Investor Letter, a copy of which you can download here.
Is Esperion Therapeutics (ESPR) Stock a Buy For 2021?
Baron Discovery Fund recently published its fourth-quarter commentary – a copy of which can be downloaded here.
Is ESPR A Good Stock To Buy Now?
We at Insider Monkey have gone over 817 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of September...
Should Value Investors Buy Esperion Therapeutics (ESPR) Stock?
Baron Discovery Fund recently published its third-quarter commentary – a copy of which can be downloaded here.
Do Hedge Funds Love Esperion Therapeutics (ESPR)?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Billionaire Hedge Funds
